Inflammatory bowel disease, IBD, is a condition that causes irritation and ulcers in the gastrointestinal tract. It is a group of inflammatory conditions of the large intestine and, in some cases, the small intestine. It is often connected with iron deficiency.

2. The most common for IBD are
ulcerative colitis and Crohn's disease.
Anemia caused by iron deficiency due
to gastrointestinal blood loss and
reduced iron absorption due to
inflammation is often present.
It may also be exacerbated by a
restrictive diet.

4. Treatment today consists mainly of
oral non-heme iron prior to
intravenous iron and erythropoietin
treatment.
The prevalence of intolerance towards
oral non-heme iron is however high,
around 25 %.

5. The absorption of heme iron is several
times higher and the side-effects rate
significantly lower than for non-heme
oral iron.
Heme iron is absorbed through a
separate pathway and does not have
to be discontinued when intravenous
treatment is started.

6. This can allow for longer intervals
between resource-heavy, inconvenient
and painful injections.
Intravenous treatment is usually
started only when oral non-heme
treatment fails due to side-effects.

7. This point can occur later in time
with self-medication heme iron
because of better tolerance.
It would thus mean a significant gain
in the patient quality of life. It gives
freedom to travel, for instance.

9. Swedish company MediTec Group AB in its
division FerroCare has a strong
commitment to reach people that are
suffering from iron deficiency and have
problems with existing supplements
Iron deficiency is easily corrected using
products from the OptiFer® series

10. Please feel free to contact us. We are looking for international distributors
www.meditec.se/FerroCare.html www.hemeiron.com